OncoMatch

OncoMatch/Clinical Trials/NCT04974346

Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer

Is NCT04974346 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies non-drug interventions for cervical cancer.

Phase 3RecruitingZhejiang Cancer HospitalNCT04974346Data as of May 2026

Para-aortic lymph node metastasis is a poor prognostic factor for locally advanced cervical cancer, but false negative diagnosis is easy to occur. The aim of this trial was to investigate whether para-aortic prophylactic radiotherapy improves disease-free survival in patients with positive pelvic lymph nodes below the common iliac artery.

Check if I qualify

Extracted eligibility criteria

Cancer type

Cervical Cancer

Disease stage

Required: Stage ⅠB2, ⅡA, ⅡB, ⅢA, ⅢB, ⅣA (FIGO 2009)

According to International Federation of Gynecology and Obstetrics(FIGO) 2009 stage, stage ⅠB2 - ⅣA with positive pelvic lymph nodes and negative common iliac and paraaortic lymph nodes diagnosed by PET-CT

Performance status

ECOG 0–1(Restricted strenuous activity)

Prior therapy

No prior treatment (treatment-naive required)
Max 0 prior lines

Cannot have received: anti-tumor treatment

The patient has received anti-tumor treatment

Cannot have received: radiotherapy for pelvic malignant tumor

Previous radiotherapy for pelvic malignant tumor

Cannot have received: pelvic artery embolization

Patients with previous pelvic artery embolization

Lab requirements

Kidney function

No chronic renal insufficiency or renal failure

Liver function

No liver cirrhosis, decompensated liver disease

Cardiac function

No myocardial infarction, severe arrhythmia, or grade 2 or more congestive heart failure (NYHA classification)

Liver cirrhosis, decompensated liver disease, chronic renal insufficiency and renal failure; Myocardial infarction, severe arrhythmia and grade 2 or more congestive heart failure (NYHA classification) [excluded]

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify